← All organizations
Highest phase reached
Phase 2
First clinical trial
Mar 29, 2019Last known activity
Aug 31, 2019
Acquired by Roivant Sciences, Inc. → Sumitomo → Sumitomo Dainippon on Jan 1, 2018
Timeline
2000s
- Jan 1, 2005
Sumitomo Dainippon— Now
2010s
- Jan 1, 2018
Respivant Sciences Inc.— Founded
- Jan 1, 2018
Roivant Sciences, Inc.— Acquired By
Drugs by trial phase (1 distinct, 2 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT04007120CollaboratorPhase 1Aug 31, 2019
- NCT04007120Lead sponsorPhase 1Aug 31, 2019
- NCT03864328CollaboratorPhase 2Mar 29, 2019
- NCT03864328Study directorPhase 2Mar 29, 2019
- NCT03864328Lead sponsorPhase 2Mar 29, 2019
Details
- Founded
- San Diego, CA, US Jan 1, 2018
- Last known activity
- Aug 31, 2019